Search
Close this search box.
Search
Close this search box.
Search
Close this search box.

South Africa

AACSB Sets Direction for Business Schools to Lead in AI

AACSB uses new report and global events to set strategic direction for business schools to advance education and lead boldly in AI. TAMPA, Fla., June 28, 2024 (GLOBE NEWSWIRE) — AACSB International (AACSB) is leading the way for business schools to utilize and innovate with AI. With a recently released

A21 Launches Host Applications for Walk for Freedom 2024

Celebrating a Decade of Impact DALLAS, TX, June 26, 2024 (GLOBE NEWSWIRE) — A21, a global nonprofit organization dedicated to eradicating human trafficking through awareness, intervention, and aftercare, is thrilled to announce that applications to become a host for the 2024 Walk For Freedom are now live. This year marks

Anaqua Launches AI-Powered IP Management Platform AQX® 11

New IP management platform drives efficiency and surfaces insights empowering organizations to excel in a competitive landscape BOSTON, June 26, 2024 (GLOBE NEWSWIRE) — Anaqua, the leading provider of innovation and intellectual property (IP) management technology, today announces the launch of AI-powered AQX® 11—Anaqua’s most significant platform release in 20

FreedomPay and Toast Survey Reveals Top Priorities for Enterprise Hospitality Leaders: Data Security, Integration, and Growth Enablement

Integration and Customer Support Emerge as Crucial Factors in Merchant Preferences for Payment Solutions Philadelphia, Pennsylvania, June 25, 2024 (GLOBE NEWSWIRE) — A recent survey conducted by FreedomPay, a global leader in Next Level Commerce™ solutions, in collaboration with Toast, a leading cloud-based restaurant management software company, has unveiled crucial

Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa

Acino gains commercial rights for EXBLIFEP® (cefepime/enmetazobactam) within the member states of the Gulf Cooperation Council (GCC) and South Africa. EXBLIFEP® has been approved by the U.S. Food and Drug Administration (FDA) and the European Commission (EC) for the treatment of severe infections earlier in 2024. Saint-Louis, France and Weil

RECENT NEWS

Copyright © 2024 Pakistan Press Release Point. All rights reserved.